A 10,000 member PNA-encoded peptide library for profiling tyrosine kinases

ACS Chemical Biology

Volumn 2, Issue 12, 2007, Pages 810-818

  Pouchain, Delphine ^a   Díaz Mochón, Juan J ^a   Bialy, Laurent ^a   Bradley, Mark ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE GAMMA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; G PROTEIN COUPLED RECEPTOR KINASE 6; PEPTIDE LIBRARY; PEPTIDE NUCLEIC ACID; PROLINE; PROTEIN C JUN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBODY LABELING; ARTICLE; DNA MICROARRAY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE EXPRESSION PROFILING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING;

PEPTIDE LIBRARY; PEPTIDE NUCLEIC ACIDS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES;

EID: 38649143228     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb700199k     Document Type: Article

References (50)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome, Science 298, 1912-1934.
2. Blume-Jensen, P., and Hunter, T. (2001) Oncogenic kinase signalling, Nature 411, 355-365.
3. Cohen, P. (2002) Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discovery 1, 309-315.
4. Rowley, J. D. (1990) The philadelphia chromosome translocation a paradigm for understanding leukemia, Cancer 65, 2178-2184.
5. Till, J. H., Chan, P. M., and Miller, W. T. (1999) Engineering the substrate specificity of the Abl tyrosine kinase, J. Biol. Chem. 274, 4995-5003.
6. Asano, T., Ikegaki, I., Satoh, S.-I., Seto, M., and Sasaki, Y. (1998) A protein kinase inhibitor, Fasudil (AT-877): a novel approach to signal transduction therapy, Cardiovasc. Drug Rev. 16, 76-87.
7. Sehgal, S. N. (1998) Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blackade of signal transduction and inhibition of cell cycle progression, Clin. Biochem. 31, 335-340.
8. Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., and Lydon, N. B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells, Nat. Med. 2, 561-566.
9. Barker, A. J., Gibson, K. H., Grundy, W., Godfrey, A. A., Barlow, J. J., Healy, M. P., Woodburn, J. R., Ashton, S. E., Curry, B. J., Scarlett, L., Henthorn, L., and Richards, L. (2001) Studies leading to the identification of ZD1839 (Iressa): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer, Bioorg. Med. Chem. Lett. 11, 1911-1914.
10. Noble, M. E. M., Endicott, J. A., and Johnson, L. N. (2004) Protein kinase inhibitors: insights into drug design from structure, Science 303, 1800-1805.
11. Songyang, Z., Carraway III, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., and Cantley, L. C. (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling, Nature 373, 536-539.
12. Hutti, J. E., Jarrell, E. T., Chang, J. D., Abbott, D. W., Storz, P., Toker, A., Cantley, L. C., and Turk, B. E. (2004) A rapid method for determining protein kinase phosphorylation specificity, Nat. Methods 1, 27-29.
13. Cujec, T. P., Medeiros, P. F., Hammond, P., Rise, C., and Kreider, B. L. (2002) Selection of v-Abl tyrosine kinase substrate sequences from randomized peptide and cellular proteomic libraries using mRNA display, Chem. Biol. 9, 253-264.
14. Kim, Y.-G., Shin, D.-S., Kim, E.-M., Park, H.-Y., Lee, C.-S., Kim, J.-H., Lee, B.-S., Lee, Y.-S., and Kim, B.-G. (2007) High-throughput identification of substrate specificity for protein kinase by using an improved one-bead-one-compound library approach, Angew. Chem., Int. Ed. 46, 5408-5411.
15. Pastor, J. J., Lingard, I., Bhalay, G., and Bradley, M. (2003) Ion-extraction ladder sequencing from bead-based libraries, J. Comb. Chem. 5, 85-90.
16. Shults, M. D., Kozlov, I. A., Nelson, N., Kermani, B. G., Melnyk, P. C., Shevchenko, V., Srinivasan, A., Musmacker, J., Hachmann, J. P., Barker, D. L., Lebl, M., and Zhao, C. (2007) A multiplexed protein kinase assay, ChemBioChem 8, 933-942.
17. Min, D.-H., Su, J., and Mrksich, M. (2004) Profiling kinase activities by using a peptide chip and mass spectrometry, Angew. Chem., Int. Ed. 43, 5973-5977.
18. Frank, R. (1992) Spot-synthesis an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support, Tetrahedron 48, 9217-9232.
19. Schutkowski, M., Reimer, U., Panse, S., Dong, L., Lizcano, J. M., Alessi, D. R., and Schneider-Mergener, J. (2004) High-content peptide microarrays for deciphering kinase specificity and biology, Angew. Chem., Int. Ed. 43, 2671-2674.
20. Diaz-Mochon, J. J., Bialy, L., Keinicke, L., and Bradley, M. (2005) Combinatorial libraries - from solution to 2D microarrays, Chem. Commun. 11, 1384-1386.
21. Diaz-Mochon, J. J., Bialy, L., and Bradley, M. (2006) Dual colour, microarray-based, analysis of 10 000 protease substrates, Chem. Commun. 38, 3984-3986.
22. Winssinger, N., Harris, J. L., Backes, B. J., and Schultz, P. G. (2001) From split-pool libraries to spatially addressable microarrays and its application to functional proteomic profiling, Angew. Chem., Int. Ed. 40, 3152-3155.
23. Winssinger, N., Damoiseaux, R., Tully, D. C., Geierstanger, B. H., Burdick, K., and Harris, J. L. (2004) PNA-encoded protease substrate microarrays, Chem. Biol. 11, 1351-1360.
24. Brenner, S., and Lemer, R. A. (1992) Encoded combinatorial chemistry, Proc. Natl. Acad. Sci. U.S.A. 89, 5381-5383.
25. Bialy, L., Diaz-Mochon, J. J., Specker, E., Keinicke, L., and Bradley, M. (2005) Dde-protected PNA monomers, orthogonal to Fmoc, for the synthesis of PNA-peptide conjugates, Tetrahedron 61, 8295-8305.
26. Diaz-Mochon, J. J., Bialy, L., and Bradley, M. (2004) Full orthogonality between Dde and Fmoc: the direct synthesis of PNA-peptide conjugates, Org. Lett. 6, 1127-1129.
27. Diaz-Mochon, J. J., Bialy, L., Watson, J., Sanchez-Martin, R. M., and Bradley, M. (2005) Synthesis and cellular uptake of cell delivering PNA-peptide conjugates, Chem. Commun. 26, 3316-3318.
28. Brenner, S., Williams, S. R., Vermaas, E. H., Storck, T., Moon, K., McCollum, C., Mao, J.-I, Luo, S., Kirchner, J. J., Eletr, S., DuBridge, R. B., Burcham, T., and Albrecht, G. (2000) In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAs, Proc. Natl. Acad. Sci. U.S.A. 97, 1665-1670.
29. Weller, J., Gausepohl, H., Hauser, N., Jensen, O. N., and Hoheisel, J. D. (1997) Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays, Nucleic Acids Res. 25, 2792-2799.
30. Pendergast, A. M. (2002) The Abl family kinases: mechanisms of regulation and signaling, Adv. Cancer Res. 85, 51-100.
31. Horiuchi, K. Y., Wang, Y., Diamond, S. L., and Ma, H. (2006) Microarrays for the functional analysis of the chemical-kinase interactome, J. Biomol. Screen. 11, 48-56.
32. Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M.-C., Estreicher, A., Gasteiger, E., Martin, M. J., Michoud, K., O'Donovan, C., Phan, I., Pilbout, S., and Schneider, M. (2003) The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003, Nucleic Acids Res. 31, 365-370.
33. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res. 25, 3389-3402.
34. Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D., and Miki, Y. (2005) JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage, Nat. Cell Biol. 7, 278-285.
35. Dürig, J., Schmücker, U., and Dührsen, U. (2001) Differential expression of chemokine receptors in B cell malignancies, Leukemia 15, 752-756.
36. Tanos, B., and Pendergast, A. M. (2006) Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor, J. Biol. Chem. 281, 32714-32723.
37. Ushio-Fukai, M., Zuo, L., Ikeda, S., Tojo, T., Patrushev, N. A., and Alexander, R. W. (2005) cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT 1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy, Circ. Res. 97, 829-836.
38. Yamada, K., Sakane, F., Imai, S.-I., Tsushima, S., Murakami, T., and Kanoh, H. (2003) Regulatory role of diacylglycerol kinase γ in macrophage differentiation of leukemia cells, Biochem. Biophys. Res. Commun. 305, 101-107.
39. Hayes, D. F., Thor, A. D., Dressler, L. G., Weaver, D., Edgerton, S., Cowan, D., Broadwater, G., Goldstein, L. J., Martino, S., Ingle, J. N., Henderson, I. C., Norton, L., Winer, E. P., Hudis, C. A., Ellis, M. J., and Berry, D. A. (2007) Her2 and response to paclitaxel in node-positive breast cancer, N. Engl. J. Med. 357, 1496-1506.
40. Olsson, A.-K, Dimberg, A., Kreuger, J., and Claesson-Welsh, L. (2006) VEGF receptor signalling-in control of vascular function, Nat. Rev. Mol. Cell Biol. 7, 359-371.
41. Eller, M., Jarv, J., Toomik, R., Ragnarsson, U., Ekman, P., and Engstrom, L. (1993) Substrate specificity of protein kinase C studied with peptides containing D-amino acid residues, J. Biochem. 114, 177-180.
42. Sen, S., Zhou, H., and White, R. A. (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines, Oncogene 14, 2195-2200.
43. Negro, A., Brar, B K, Gu, Y., Peterson, K. L., Vale, W., and, and Lee, K.-F (2006) ErbB2 is required for G protein-coupled receptor signaling the Heart, Proc. Natl. Acad. Sci. U.S.A. 103, 15889-15893.
44. Fox, B. P., and Kandpal, R. P. (2004) Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application, Biochem. Biophys. Res. Commun. 318, 882-892.
45. Gonzalez, R. R., Cherfils, S., Escobar, M., Yoo, J. H., Carino, C., Styer, A. K., Sullivan, B. T., Sakamoto, H., Olawaiye, A., Serikawa, T., Lynch, M. P., and Rueda, B. R. (2006) Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2), J. Biol. Chem. 281, 26320-26328.
46. Singh, A. J., Meyer, R. D., Band, H., and Rahimi, N. (2005) The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation, Mol. Biol. Cell 16, 2106-2118.
47. Endo, A., Nagashima, K.-I., Kurose, H., Mochizuki, S., Matsuda, M., and Mochizuki, N. (2002) Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and Crkll, J. Biol. Chem. 277, 23747-23754.
48. Chhabra, S. R., Hothi, B., Evans, D. J., White, P. D., Bycroft, B. W., and Chan, W. C. (1998) An appraisal of new variants of Dde amine protecting group for solid phase peptide synthesis, Tetrahedron Lett. 39, 1603-1606.
49. Zhao, Z. G., Im, J. S., Lam, K. S., and Lake, D. F. (1999) Site-specific modification of a single-chain antibody using a novel glyoxylyl-based labeling reagent, Bioconjugate Chem. 10, 424-430.
50. Fischer, R., Mader, O., Jung, G., and Brock, R. (2003) Extending the applicability of carboxyfluorescein in solid-phase synthesis, Bioconjugate Chem. 14, 653-660.